APH vs SPRB · P/E 40, rev $23.09B vs rev $4.9M
Amphenol Corporation (APH) versus Spruce Biosciences Inc (SPRB) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. SPRB currently screens at market cap $3.0M.
Not investment advice. Open the APH and SPRB stock pages for the full models.
Not investment advice.